Statin induced myopathy differential diagnosis

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby

Statin induced myopathy Microchapters

Home

Patient Info

Overview

Classification

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Differentiating Statin induced myopathy from other Diseases

Diagnosis

History & Symptoms

Lab Tests

Treatment

Medical Therapy

Statin induced myopathy differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Statin induced myopathy differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Statin induced myopathy differential diagnosis

CDC on Statin induced myopathy differential diagnosis

Statin induced myopathy differential diagnosis in the news

Blogs on Statin induced myopathy differential diagnosis

Directions to Hospitals Treating Statin induced myopathy

Risk calculators and risk factors for Statin induced myopathy differential diagnosis

Overview

Myalgia is a common complaint and should not be attributed directly to the use of statins. The patient should be evaluated for any thyroid problems, inflammatory processes, alcohol use, excessive exercise, electrolyte disturbances, side effects of other medications or vitamin deficiencies.

Differential Diagnosis

References

  1. Fernandez G, Spatz ES, Jablecki C, Phillips PS (2011). "Statin myopathy: a common dilemma not reflected in clinical trials". Cleve Clin J Med. 78 (6): 393–403. doi:10.3949/ccjm.78a.10073. PMID 21632911.